retatrutide expanded access program eli lilly Lilly, with new data, to seek FDA approval of obesity drug Retatrutide, Eli Lilly's next obesity

Clinical trials have shown promising results for Retatrutide: Retatrutide is an innovative solution designed for individuals who have struggled to achieve meaningful weight loss through traditional methods such as diet, exercise, or lifestyle modifications

however, people should check with the employer on specific rules and time limits

Article 7 mins Aon CEO Greg Case: Success in a World of New and Increasingly Volatile Risks In this interview, Greg Case, the CEO of Aon, discusses the challenges that businesses are facing due to the pandemic, cyber risks, and the impacts of climate change

While GLP-1 RAs are not contraindicated for many of these conditions, practical precautions such as avoiding GLP-1 RA initiation during inflammatory bowel disease exacerbation may reduce the risk of AEs